Sperm associated antigen 9 (SPAG9) expression and humoral response in benign and malignant salivary gland tumors

References

• Suri A, Saini S, Sinha A, Agarwal S, Verma A, Parashar D, Singh S, Gupta N, Jagadish N. Cancer testis antigen: A new paradigm for cancer therapy. Oncoimmunology 2012; 1:1194-96; PMID:23170277
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2013. CA Cancer J Clin 2013; 62:10-29; PMID:23335087; http://dx.doi.org/10.3322/caac.20138
   PubMed Web of Science ®Google Scholar
• Yeole BB. An assessment of improvement in reliability and completeness of Mumbai cancer registry data from 1965–1997. Asian Pacific J Cancer Prev 2001; 2:225-232; PMID:12718635
   PubMedGoogle Scholar
• Speight PM, Barrett AW. Salivary gland tumours. Oral Dis 2002; 8:229-240; PMID:12363107; http://dx.doi.org/10.1034/j.1601-0825.2002.02870.x
   PubMed Web of Science ®Google Scholar
• Guzzo M, Locati LD, Prott FZ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol 2010; 74:134-148; PMID:19939701; http://dx.doi.org/10.1016/j.critrevonc.2009.10.004
   PubMed Web of Science ®Google Scholar
• Locati LD, Perrone F, Losa M, Mela M, Casieri P, Orsenigo M, Cortelazzi B, Negri T, Tamborini E, Quattrone P, et al. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol 2009; 45:986-990; PMID:19574086; http://dx.doi.org/10.1016/j.oraloncology.2009.05.635
   PubMed Web of Science ®Google Scholar
• Ethunandan M, Witton R, Hoffman G, Spedding A, Brennan PA. Atypical features in pleomorphic adenoma–a clinicopathologic study and implications for management. Int J Oral Maxillo fac Surg 2006; 35:608-12; PMID:16540285; http://dx.doi.org/10.1016/j.ijom.2006.02.009
   PubMed Web of Science ®Google Scholar
• Matse JH, Yoshizawa J, Wang X, Elashoff D, Bolscher JGM, Veerman ECI, Bloemena E, Wong DTW. Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors. Clin Cancer Res 2013; 19:3032-38; PMID:23575476
   PubMed Web of Science ®Google Scholar
• Rodríguez MS, Reija MF, Rodilla IG. Primary clear cell carcinoma of parotid gland: Case report and review of literature. J Oral Maxillofac Pathol 2013; 17:101-5; PMID:23798840; http://dx.doi.org/10.4103/0973-029X.110692
   PubMedGoogle Scholar
• Glisson B, Colevas AD, Haddad R, Krane J, El-Naggar A, Kies M, Costello R, Summey C, Arquette M, Langer C, et al. HER2 expression in Salivary Gland Carcinomas: dependence on Histological Subtype. Clin Cancer Res 2004; 10:944-46; PMID:14871971; http://dx.doi.org/10.1158/1078-0432.CCR-03-0253
   PubMed Web of Science ®Google Scholar
• Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer 2005; 103:2544-50; PMID:15880750; http://dx.doi.org/10.1002/cncr.21083
   PubMed Web of Science ®Google Scholar
• Kalejs M, Erenpreisa J. Cancer/testis antigens and gametogenesis: a review and "brain-storming" session. Cancer Cell Int 2005; 5:4-14; PMID:15715909; http://dx.doi.org/10.1186/1475-2867-5-4
   PubMed Web of Science ®Google Scholar
• Nagel H, Laskawi R, Eiffert H, Schlott T. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands. J Clin Pathol: Mol Pathol 2003; 56:226-31; PMID:12890744
   PubMed Web of Science ®Google Scholar
• Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, et al. Sperm associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res 2007; 13:1421-28; PMID:17332284; http://dx.doi.org/10.1158/1078-0432.CCR-06-2340
   PubMed Web of Science ®Google Scholar
• Garg M, Kanojia D, Khosla A, Dudha N, Sati S, Chaurasiya D, Jagadish N, Seth A, Kumar R, Gupta S, et al. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Cancer Res 2008; 68:8240-48; PMID:18922895; http://dx.doi.org/10.1158/0008-5472.CAN-08-1708
   PubMed Web of Science ®Google Scholar
• Garg M, Kanojia D, Suri S, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9: a novel diagnostic marker for thyroid cancer. J Clin Endocrinol Metab 2009; 94:4613-18; PMID:19820019; http://dx.doi.org/10.1210/jc.2009-0703
   PubMed Web of Science ®Google Scholar
• Garg M, Kanojia D, Salhan S, Suri S, Gupta A, Lohiya NK, Suri A. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma. Cancer 2009; 115:2671-83; PMID:19326449; http://dx.doi.org/10.1002/cncr.24293
   PubMed Web of Science ®Google Scholar
• Kanojia D, Garg M, Gupta S, Gupta A and Suri A. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 8:630-39; PMID:19190149; http://dx.doi.org/10.1158/1055-9965.EPI-08-0629
   PubMed Web of Science ®Google Scholar
• Kanojia D, Garg M, Gupta S, Gupta A and Suri A. Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity. Am J Pathol 2011; 178:1009-20; PMID:21356354; http://dx.doi.org/10.1016/j.ajpath.2010.11.047
   PubMed Web of Science ®Google Scholar
• Kanojia D, Garg M, Saini S, Agarwal S, Parashar D, Jagadish N, Seth A, Bhatnagar A, Gupta A, Kumar R, et al. Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma. PLoS One 2013; 8(12): e81348; PMID:24349057; http://dx.doi.org/10.1371/journal.pone.0081348
   PubMed Web of Science ®Google Scholar
• Yu P, Yan L, Zhang H, Lin X, Zhao X. Expression and clinical significance of Sperm-Associated Antigen 9 in patients with endometrial carcinoma. Int J Gynaecol Cancer; 2012; 22: 87-93; PMID:22146769; http://dx.doi.org/10.1097/IGC.0b013e3182370f2e
   PubMed Web of Science ®Google Scholar
• Wang Y, Dong Q, Miao Y, Fu L, Lin X. Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer. Lung Cancer; 2013; 2:266-72; PMID:23711689; http://dx.doi.org/10.1016/j.lungcan.2013.04.021
   PubMedGoogle Scholar
• Yi F, Ni W, Liu W, Pan X, Han X, Yang L, Kong X, Ma R, Chang R. SPAG9 is overexpressed in human astrocytoma and promotes cell proliferation and invasion. Tumour Biol; 2013; 34:2849-55; PMID:23696027 ; http://dx.doi.org/10.1007/s13277-013-0845-5
   PubMed Web of Science ®Google Scholar
• Gao J, Panizza B, Johnson NW, Coman S, Clough AR. Basic consideration of research strategies for head and neck cancer. Front Med; 2012; 6:339-53; PMID:23054500; http://dx.doi.org/10.1007/s11684-012-0213-7
   PubMedGoogle Scholar
• Murase R, Sumida T, Ishikawa A, Murase R, McAllister SD, Hamakawa H, Desprez P. Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer. Int J Oto laryngol; 2011:187623-7631; PMID:22164169
   PubMedGoogle Scholar
• Liao W, Guo L, Zhong Y, Wu Y, Li J, Song L. Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma. J Transl Med; 2011; 9:205-14; PMID:22133054; http://dx.doi.org/10.1186/1479-5876-9-205
   PubMed Web of Science ®Google Scholar
• Xie C, Fu L, Liu N, Li Q. Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma. Tumour Biol 2014; 35:7685-91; PMID:24801907; http://dx.doi.org/10.1007/s13277-014-2030-x
   PubMedGoogle Scholar
• Agarwal S, Saini S, Parashar D, Verma A, Sinha A, Jagadish N, Batra A, Suri S, Gupta A, Ansari AS, et al. The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma. OncoImmunology; 2013; 2:e24270-278; PMID:23762804; http://dx.doi.org/10.4161/onci.24270
   PubMed Web of Science ®Google Scholar
• Saini S, Jagadish N, Gupta A, Bhatnagar A, Suri A. A novel cancer testis antigen, a-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer. PLoS ONE 2013; 8(2): e57095; PMID:23451156; http://dx.doi.org/10.1371/journal.pone.0057095
   PubMed Web of Science ®Google Scholar
• Agarwal S, Saini S, Parashar D, Verma A, Jagadish N, Batra A, Suri S, Bhatnagar A, Gupta A, Ansari AS, et al. Expression and humoral response of a-kinase anchor protein 4 in cervical cancer. Int J Gynecol Cancer 2013; 4:650-58; PMID:23478221; http://dx.doi.org/10.1097/IGC.0b013e31828a0698
   PubMed Web of Science ®Google Scholar
• Ashkavandi ZJ, Najvani AD, Tadbir AA, Pardis S, Ranjbar MA, Ashraf MJ. MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors. Asian Pac J Cancer Prev 2013; 14:3479-82; PMID:23886132; http://dx.doi.org/10.7314/APJCP.2013.14.6.3479
   PubMedGoogle Scholar
• Baser E, Togrul C, Ozgu E, Ayhan S, Caglar M, Erkaya S, Gungor T. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial Cancer. Asian Pac J Cancer Prev 2012; 14:7635-38; PMID:24460345; http://dx.doi.org/10.7314/APJCP.2013.14.12.7635
   PubMedGoogle Scholar
• Jagadish N, Rana R, Selvi R, Mishra D, Garg M, Yadav S, Herr JC, Okumura K, Hasegawa A, Koyama K, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem J 2005; 389:73-82; PMID:15693750; http://dx.doi.org/10.1042/BJ20041577
   PubMed Web of Science ®Google Scholar